This is the first time that citizens outside of global clinical trials will have the opportunity to be immunized against Covid-19, says Ugur Sahin, CEO of BioNTech.
The vaccine will be available across the UK from next week, a Department of Health and Social Affairs spokesman said in a statement. More details will appear soon, including advice for priority groups such as the elderly and health care staff to get the vaccine.
“To help the vaccination program succeed, it is essential that everyone continues to play a role and adhere to the necessary restrictions in their area so we can further suppress the virus and allow the NHS to do its job without overload,” the spokesman said.
“The vaccine will be available across the UK from next week. The NHS has decades of experience in implementing large-scale vaccination programs and is starting comprehensive preparations to provide care and support to those vaccinated.” he added.
In a press release, Albert Bourla, CEO of Pfizer, welcomed the emergency license as “a historic moment in the fight against Covid-19.”
“This license is a goal we have been working on since we first declared that science will win and applaud (the Agency for the Regulation of Medicines and Health Products) for their ability to make careful assessments and take timely action to protect the human population. United Kingdom, “he said.
Sahin added that the regulatory data was created as a result of a “scientifically rigorous and highly ethical research and development program.”
The companies have previously signed an agreement to deliver 40 million servings to the UK in 2020 and 2021.
Other countries, including the United States, are considering approving various coronavirus vaccines before the end of the year.